mitomycin has been researched along with dacarbazine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Droz, JP; Herait, P; Kac, JL; Rougier, P; Theodore, C | 1 |
| Portnoĭ, AS | 1 |
| Burgess, M; Pasterz, R; Savaraj, N | 1 |
| Voigt, H | 1 |
| Falkson, G; Falkson, HC; Pretorius, HL; Schoeman, HS | 1 |
| Evans, M; Hellmann, K; Jones, R; Newton, K; Peters, N; Phillips, RH; Smith, BJ | 1 |
| Cook, RL; Houghton, JA; Houghton, PJ; Lutz, PJ | 1 |
| Cassady, JR; Frantz, CN; Kretschmar, C; Levey, R; Rosen, EM; Sallan, SE; Vawter, G | 1 |
| Brodsky, I; Bulova, SI; Conroy, JF; Kahn, SB; Pequignot, E; Roda, PI | 1 |
| Campbell, ED; Carter, WH; Stablein, DM; Wampler, GL | 1 |
| Belliveau, JF; Darnowski, JW; Leenen, L; Turk, PS; Wanebo, HJ; Weinberg, MC | 1 |
| Dispenzieri, A; Loprinzi, CL | 1 |
| Allan, JM; Broekhof, JL; Carls, NH; Donker, I; Engelward, BP; Glassner, BJ; Hampson, RJ; Hersmus, R; Hickman, MJ; Hoeijmakers, JH; Roth, RB; Samson, LD; Warren, HB; Weeda, G; Wu, MM | 1 |
| Buckner, JC; Edmonson, JH; Mahoney, MR; Marks, RS | 1 |
| Cupissol, D; Cuq, P; Depeille, P; Evrard, A; Passagne, I; Vian, L | 1 |
| Blessing, JA; Long, HJ; Sorosky, J | 1 |
| Fabian, K; Kaina, B; Thacker, J; Tsaryk, R | 1 |
| Aydincak, O; Baykaner, K; Emmez, H; Kurt, G; Memis, L; Sepici, A; Yilmaz, MB | 1 |
2 review(s) available for mitomycin and dacarbazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Chemotherapy of prostatic cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dacarbazine; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Hydroxyurea; Male; Melphalan; Methotrexate; Mitomycin; Mitomycins; Prednisolone; Procarbazine; Prostatic Neoplasms; Streptozocin; Vincristine | 1985 |
2 trial(s) available for mitomycin and dacarbazine
| Article | Year |
|---|---|
Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Female; Gastrointestinal Neoplasms; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Intravenous; Leiomyosarcoma; Male; Middle Aged; Mitomycin; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 2002 |
Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leiomyosarcoma; Leukopenia; Middle Aged; Mitomycin; Recombinant Proteins; Uterine Neoplasms | 2005 |
20 other study(ies) available for mitomycin and dacarbazine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Alternating 5-FU-mitomycin C/5-FU-dacarbazine in advanced colorectal adenocarcinoma: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dacarbazine; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins | 1989 |
Prognostic factors in metastatic carcinoma of unknown primary.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms, Unknown Primary; Prognosis; Skin Neoplasms; Statistics as Topic; Tegafur; Vincristine | 1986 |
Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
Topics: Adolescent; Adult; Aging; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Femoral Neoplasms; Fibula; Humans; Humerus; Lung Neoplasms; Male; Methotrexate; Mitomycin; Mitomycins; Osteosarcoma; Prognosis; Radiotherapy Dosage; Tibia; Time Factors; Vincristine | 1988 |
[Regional intra-arterial chemotherapy].
Topics: Cisplatin; Dacarbazine; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Melanoma; Mitomycin; Mitomycins | 1988 |
Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Dacarbazine; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Rectal Neoplasms; Vincristine | 1983 |
Inefficacy of dacarbazine, mitomycin C, and hepatic irradiation in patients with metastatic adenocarcinoma of the gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Middle Aged; Mitomycin; Mitomycins | 1984 |
Childhood rhabdomyosarcoma xenografts: responses to DNA-interacting agents and agents used in current clinical therapy.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Child; Cisplatin; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Humans; Melphalan; Mice; Mice, Inbred CBA; Mitomycin; Mitomycins; Neoplasm Transplantation; Rhabdomyosarcoma; Transplantation, Heterologous; Vincristine | 1984 |
Improved survival in neuroblastoma using multimodality therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Humans; Infant; Mechlorethamine; Mitomycin; Mitomycins; Neuroblastoma; Prognosis; Radiotherapy, High-Energy; Vincristine | 1984 |
Efficacy of dacarbazine imidazole carboxamide and mitomycin C combination therapy in patients with adenocarcinoma of the colon refractory to 5-fluorouracil therapy.
Topics: Adenocarcinoma; Colonic Neoplasms; Dacarbazine; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Radionuclide Imaging; Time Factors | 1981 |
Drug activity and therapeutic synergism in cancer treatment.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Melanoma; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Rats; Razoxane; Teniposide | 1982 |
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Catheterization; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dacarbazine; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Palliative Care; Pelvis; Rectal Neoplasms; Remission Induction | 1993 |
Chemotherapy-induced insulin-dependent diabetes mellitus.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Dexamethasone; Diabetes Mellitus, Type 1; Doxorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Jejunal Neoplasms; Leiomyosarcoma; Male; Middle Aged; Mitomycin | 1997 |
DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Carcinogens; Carmustine; Dacarbazine; Genotype; Hematopoietic System; Liver; Methylnitronitrosoguanidine; Mice; Mice, Knockout; Mitomycin; Models, Biological; O(6)-Methylguanine-DNA Methyltransferase; Streptozocin; Temozolomide | 1999 |
O(6)-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C.
Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cell Line, Tumor; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Inhibitory Concentration 50; Melanoma; Mitomycin; Nitrosourea Compounds; O(6)-Methylguanine-DNA Methyltransferase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Temozolomide; Transfection | 2006 |
Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cisplatin; Cyclophosphamide; Dacarbazine; DNA-Binding Proteins; Humans; Methylnitronitrosoguanidine; Mitomycin; Mutagens; Nitrosourea Compounds; Organophosphorus Compounds; Temozolomide | 2006 |
The effect of temozolomide on the prevention of epidural fibrosis developing after lumbar laminectomy in rats.
Topics: Animals; Dacarbazine; Dura Mater; Epidural Space; Fibroblasts; Fibrosis; Laminectomy; Lumbar Vertebrae; Male; Mitomycin; Rats; Rats, Wistar; Temozolomide | 2012 |